Study Stopped
We have finished all data collection for phase I and are not ready to start phase II
Exoskeleton Use With In Home Functional Activities
The Observation of Exoskeleton Use With In Home Functional Activities
1 other identifier
observational
12
1 country
1
Brief Summary
The purpose of this study is to observe current exoskeleton users in their home environment to determine the activities of daily living (ADLs) they are able to complete, and to identify the minor adaptations to the home environment that will improve the exoskeleton user's potential for increased independence. This is a pilot study to fine-tune the methods and to determine the feasibility of doing this study on a larger scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2023
CompletedFirst Posted
Study publicly available on registry
January 24, 2024
CompletedStudy Start
First participant enrolled
February 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2025
CompletedJanuary 22, 2026
October 1, 2025
1.9 years
December 18, 2023
January 20, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Reintegration to Normal Living Index - Modified for Exoskeleton
Assesses quantitatively the degree to which individuals who have experienced traumatic or incapacitating illness achieve reintegration into normal social activities. This assessment has been modified from wheelchair level to exoskeleton level. The Reintegration to Normal Living Index has 9 Likert-style items. Each item is accompanied by verbal label choices with phrases reflecting how important the situation described is to the patient as it relates to using the exoskeleton. It allows the patients to determine the extent to which the statement in question applies to their specific situation.
baseline results will be collected same day as the home visit, same assessment will be repeated virtually at 1, 3, 6, 9, and 12 months
Brief Pain Inventory (BPI)
The BPI allows patients to rate the severity of their pain and the degree to which their pain interferes with common dimensions of feeling and function. A higher score on the BPI indicates more severe pain. Scores can range from 0-10. The BPI scale defines pain as follows: Worst Pain Score: 1 - 4 = Mild Pain. Worst Pain Score: 5 - 6 = Moderate Pain. Worst Pain Score: 7 - 10 = Severe Pain.
baseline results will be collected same day as the home visit, same assessment will be repeated virtually at 1, 3, 6, 9, and 12 months
Canadian Occupational Performance Measure (COPM)
The COPM assesses an individual's perceived occupational performance in the areas of self-care, productivity, and leisure. The COPM identifies 5 functional tasks the patient wants to improve, and rates their performance and satisfaction in their performance. Tasks are scored on a 1-10 scale (1-low; 10-high) for each item, then averaged over the 5 areas for an overall score. A higher score indicates better performance.
baseline results will be collected same day as the home visit, same assessment will be repeated virtually at 1, 3, 6, 9, and 12 months
Secondary Outcomes (1)
Journal Entries
check journal monthly up to 12 months
Study Arms (1)
Exoskeleton Users
This study includes patients who are current exoskeleton users. Exoskeleton users will engage in normal activities of daily living (ADLs) that they currently perform at wheelchair level while using the exoskeleton. Researchers will observe the ADLs the exoskeleton users are and are not able to complete while using their exoskeleton.
Interventions
The study will include one group of patients who are current exoskeleton users.
Eligibility Criteria
The population for this study is current exoskeleton users.
You may qualify if:
- At least 18 years old
- English speaking
- Trained and approved/credentialed by exoskeleton manufacturer to use the device independently according to FDA approved activities
You may not qualify if:
- Does not speak English
- \<18 years of age
- Has not been cleared by manufacturer for independent exoskeleton use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
A. T. Still University
Mesa, Arizona, 85206, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sue Dahl-Popolizio, DBH
A. T. Still University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2023
First Posted
January 24, 2024
Study Start
February 10, 2024
Primary Completion
December 28, 2025
Study Completion
December 28, 2025
Last Updated
January 22, 2026
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share